Sai Life Sciences FY26 Net Profit ₹3.49 Billion

• Board approved audited standalone and consolidated financial results for FY26 and Q4FY26 on 14 May 2026.
• Consolidated FY26 revenue grew to ₹21.92 billion with net profit of ₹3.49 billion and EPS of ₹16.63.
• Company fully utilized ₹9.10 billion IPO proceeds for debt repayment and corporate purposes as planned.
• Labour Code implementation resulted in net exceptional expense of ₹80.01 million for FY26.